We are live on ! Find out more
IHAM

Integral Health Asset Management Portfolio holdings

AUM $2.09B
1-Year Est. Return 112.84%
This Fund
S&P 500
This Quarter Est. Return
+14.32%
1 Year Est. Return
+112.84%
3 Year Est. Return
+485.32%
5 Year Est. Return
+783.01%
10 Year Est. Return
–
AUM
$889M
AUM Growth
-$164M
Cap. Flow
-$239M
Cap. Flow %
-26.87%
Top 10 Hldgs %
50.84%
Holding
103
New
31
Increased
13
Reduced
14
Closed
37

Top Buys

Rank Stock Value
1
INSP icon
Inspire Medical Systems
INSP
+$27.8M
2
MDT icon
Medtronic
MDT
+$25.2M
3
COO icon
Cooper Companies
COO
+$10.7M
4
DXCM icon
DexCom
DXCM
+$9.85M
5
FMS icon
Fresenius Medical Care
FMS
+$8.86M

Top Sells

Rank Stock Value
1
ELV icon
Elevance Health
ELV
+$43.3M
2
HUM icon
Humana
HUM
+$28M
3
UHS icon
Universal Health Services
UHS
+$24M
4
BDX icon
Becton Dickinson
BDX
+$17.5M
5
CI icon
Cigna
CI
+$16.5M

Sector Composition

Rank Sector Weight
1 Healthcare 95.57%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FMS icon
26
Fresenius Medical Care
FMS
$12.7B
$9.59M 1.08%
+450,000
New +$8.86M
BRKR icon
27
Bruker
BRKR
$8.69B
$9.32M 1.05%
135,000
+5,000
+4% +$323K
BMY icon
28
Bristol-Myers Squibb
BMY
$130B
$9.05M 1.02%
+175,000
New +$8.21M
LLY icon
29
Eli Lilly
LLY
$1.08T
$8.86M 1%
10,000
– –
DXCM icon
30
DexCom
DXCM
$33.8B
$8.04M 0.91%
+120,000
New +$9.85M
CPRX
31
DELISTED
Catalyst Pharmaceutical
CPRX
$7.95M 0.89%
400,000
+125,000
+45% +$2.32M
SANA icon
32
Sana Biotechnology
SANA
$1.05B
$7.49M 0.84%
1,800,000
+600,000
+50% +$3.15M
TFX icon
33
Teleflex
TFX
$5.91B
$7.42M 0.83%
30,000
-15,000
-33% -$3.5M
BTSG icon
34
BrightSpring Health Services
BTSG
$11.5B
$7.34M 0.83%
+500,000
New +$6.27M
CRSP icon
35
CRISPR Therapeutics
CRSP
$5.23B
$7.05M 0.79%
150,000
– –
ALNY icon
36
Alnylam Pharmaceuticals
ALNY
$29.6B
$6.88M 0.77%
+25,000
New +$6.51M
APLT
37
DELISTED
Applied Therapeutics
APLT
$6.8M 0.77%
+800,000
New +$4.71M
JSPR icon
38
Jasper Therapeutics
JSPR
$29.7M
$6.58M 0.74%
+350,000
New +$6.97M
TNDM icon
39
Tandem Diabetes Care
TNDM
$1.63B
$6.36M 0.72%
+150,000
New +$6.36M
BNTX icon
40
BioNTech
BNTX
$23.3B
$5.94M 0.67%
+50,000
New +$4.6M
QDEL icon
41
QuidelOrtho
QDEL
$959M
$5.7M 0.64%
125,000
-25,000
-17% -$1.01M
VRDN icon
42
Viridian Therapeutics
VRDN
$2.6B
$5.69M 0.64%
+250,000
New +$4.09M
EVH icon
43
Evolent Health
EVH
$464M
$5.66M 0.64%
+200,000
New +$5.16M
EXAS
44
DELISTED
Exact Sciences
EXAS
$5.45M 0.61%
+80,000
New +$4.51M
IQV icon
45
IQVIA
IQV
$40.1B
$4.74M 0.53%
+20,000
New +$4.72M
TNYA icon
46
Tenaya Therapeutics
TNYA
$168M
$4.58M 0.52%
2,375,000
+50,000
+2% +$141K
TWST icon
47
Twist Bioscience
TWST
$7.72B
$4.52M 0.51%
+100,000
New +$4.76M
NRIX icon
48
Nurix Therapeutics
NRIX
$2.69B
$4.49M 0.51%
200,000
+50,000
+33% +$1.13M
MLYS icon
49
Mineralys Therapeutics
MLYS
$2.41B
$4.31M 0.49%
+356,000
New +$4.31M
MREO
50
Mereo BioPharma
MREO
$48.8M
$4.11M 0.46%
1,000,000
-775,000
-44% -$3.21M
1
2
3 4 5

Similar funds

CL
CSS LLC Chicago, Illinois $2.09B AUM 58.96% 1-Year Est. Return
ACM
Analog Century Management New York $2.09B AUM 186.85% 1-Year Est. Return
ACG
Aventail Capital Group New York $2.09B AUM 43.81% 1-Year Est. Return
NSUP
NLB Skladi upravljanje premozenja Ljubljana $2.09B AUM
TP
Third Point New York $2.08B AUM 27.04% 1-Year Est. Return
ACP
Avantyr Capital Partners New York $2.08B AUM
TA
TruWealth Advisors Metairie, Louisiana $2.08B AUM 21.15% 1-Year Est. Return
AG
Avala Global New York $2.08B AUM 87.66% 1-Year Est. Return

Integral Health Asset Management's Q3 2024 Portfolio in Review

As of Q3 2024, Integral Health Asset Management held 103 positions worth $889M, down 16% from $1.05B the previous quarter. Its ten largest holdings account for 51% of the portfolio.

Integral Health Asset Management withdrew a net $239M in Q3 2024, closing 37 positions and reducing 14 holdings. Its most notable exit was Elevance Health, an estimated $43.3M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 96% of assets, up from 95% a quarter earlier.

Against the trend, Integral Health Asset Management opened a new position in Inspire Medical Systems worth $33.8M.

  • Integral Health Asset Management's largest Q3 2024 buy was Inspire Medical Systems: 160,000 shares worth $33.8M.
  • Integral Health Asset Management added most to Keros Therapeutics in Q3 2024, an estimated $5.68M increase.
  • Integral Health Asset Management's biggest Q3 2024 reduction was Cytokinetics, cutting an estimated $13.9M.
  • Integral Health Asset Management fully exited Elevance Health in Q3 2024, selling an estimated $43.3M.
  • Integral Health Asset Management's ten largest holdings make up 51% of its $889M portfolio in Q3 2024.
  • Integral Health Asset Management opened 31 new positions and closed 37 in Q3 2024.
  • Integral Health Asset Management's portfolio value fell 16% quarter-over-quarter to $889M.

Based on Integral Health Asset Management's 13F filing for Q3 2024, filed 14 Nov 2024.